Holen Sie sich die Stockscreener-App
97.54
5.71%
-5.91
Biontech Se Adr Aktie (BNTX) Neueste Nachrichten
BioNTech (NASDAQ:BNTX) Shares Gap DownWhat's Next? - MarketBeat
Moderna's Legal Hit Steals Spotlight From Strong Sales - Benzinga
Pfizer, BioNTech Defeat Moderna COVID Jab Patent - Law360
BioNTech (BNTX) surges 6.1%: Is this an indication of further gains? - MSN
BioNTech SE Sponsored ADR $BNTX Shares Sold by Flossbach Von Storch SE - MarketBeat
Tangible book value per share of BioNTech SE Sponsored ADR – XETR:22UA - TradingView
BioNTech SE (BNTX) Stock Price, Trades & News - GuruFocus
BioNTech SE (MEX:BNTXN) Stock Price, Trades & News - GuruFocus
BNTX Stock Price, Quote & Chart | BIONTECH SE-ADR (NASDAQ:BNTX) - ChartMill
Sierk Poetting Sells 50,000 Shares of BioNTech (NASDAQ:BNTX) Stock - MarketBeat
BioNTech (BNTX) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance
Middle East Conflict Weighs on Markets: Food Supply Chains Become a Key Issue – MustGrow, K+S, Evotec, and BioNTech in the Spotlight - news.financial
BioNTech's Pancreatic Cancer Vaccine Shows Unprecedented Long-Term Survival () - aktiencheck.de
BioNTech's Oncology Pipeline Delivers Critical Data as Strategic Pivot Accelerates () - aktiencheck.de
BNTX Earnings History & Surprises | EPS & Revenue Results | BIONTECH SE-ADR (NASDAQ:BNTX) - ChartMill
BioNTech’s Malaria mRNA Vaccine Trial Reaches Completion: What Investors Should Watch - TipRanks
Lbp Am Sa Acquires 15,255 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat
BioNTech Impfung: Between Pandemic Legacy and Oncology Pivot, Future Hinges on Pipeline Wins - AD HOC NEWS
BioNTech SE Sponsored ADR $BNTX Shares Sold by Baillie Gifford & Co. - MarketBeat
Net income of BioNTech SE Sponsored ADR – BSESOF:22UA - TradingView — Track All Markets
BioNTech SE Sponsored ADR Revenue Breakdown – BSESOF:22UA - TradingView
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
BioNTech Earnings Call: Cash-Rich Pivot Beyond COVID - TipRanks
Operating income of BioNTech SE Sponsored ADR – BSESOF:22UA - TradingView — Track All Markets
BioNTech's Shareholder Vote to Cement Post-Pandemic Strategy () - aktiencheck.de
Why Is Pfizer Stock Dropping Tuesday? - Sahm
European ADRs Slipped As Biotech Lagged And UK Names Rose - Finimize
Leerink cuts BioNTech stock price target on drug trial concerns - Investing.com
BioNTech Shifts Strategy with Dual Operational Pullbacks () - aktiencheck.de
BioNTech's Strategic Pivot: Fueling Oncology Ambition with Capital Reserves () - aktiencheck.de
BioNTech Shares Navigate Dual Challenges Amid Strategic Shift () - aktiencheck.de
BioNTech announces invitation to 2026 annual general meeting for May 15 - Investing.com
BioNTech's mRNA Vaccine Platform: Current Developments and Strategic Importance for North American I - AD HOC NEWS
HC Wainwright Issues Negative Estimate for BioNTech Earnings - MarketBeat
BioNTech (NASDAQ:BNTX) Given New $130.00 Price Target at HC Wainwright - Defense World
BioNTech SE (STU:22UA) Stock Price, Trades & News - GuruFocus
BioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know - MSN
BNTX Stock Today: March 31: ELCC Cancer Data Steady Amid Biotech Rout - Meyka
BioNTech at a Crossroads: Financial Pressures and Clinical Promise Collide () - aktiencheck.de
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Short Interest Down 20.7% in March - MarketBeat
BioNTech's Oncology Pipeline Shows Promise with Significant Survival Data () - aktiencheck.de
BioNTech SE Sponsored ADR Trade Ideas — BSESOF:22UA - TradingView
Total equity of BioNTech SE Sponsored ADR – BSESOF:22UA - TradingView
ETFs Investing in BioNTech SE Sponsored ADR Stocks - TradingView
EBITDA per share of BioNTech SE Sponsored ADR – BSESOF:22UA - TradingView
BioNTech’s Mpox Vaccine Study Reaches Completion: What Investors Should Watch Next - TipRanks
BioNTech SE Sponsored ADR $BNTX Shares Bought by SG Americas Securities LLC - MarketBeat
BioNTech (NASDAQ:BNTX) Receives Buy Rating from Jefferies Financial Group - defenseworld.net
BioNTech stock plunges as founders leave. Should you buy the dip in BNTX here? - MSN
BioNTech Oncology Pipeline Shows Promising Survival Data in Late-Stage Lung Cancer Trials as of Marc - AD HOC NEWS
BioNTech's Oncology Pipeline Advances Amid Financial Transition () - aktiencheck.de
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):